Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-29 @ 2:50 AM
Study NCT ID:
NCT01586858
Status:
TERMINATED
Last Update Posted:
2017-10-27
First Post:
2012-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
Sponsor:
Johns Hopkins University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-25
First Submit QC Date:
None
Study First Post Date:
2012-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-25
Last Update Post Date:
2017-10-27
Last Update Post Date Type:
ACTUAL